However, these p53 isoforms can certainly compromise p53-mediated tumor suppression by interfering with FLp53 binding to target genes such as p21 and miR-34a (Fujita et al., 2009; Horikawa et al., 2017) by dominant-negative effect, and the exact mechanism is not known. Here, TP53 is linked to neoplasm.